EN | 中文
NEWS
23
May
2023
OCULIS ANNOUNCES POSITIVE TOP LINE RESULTS FROM DIAMOND STAGE 1 PHASE 3 TRIAL IN DIABETIC MACULAR EDEMA WITH OCS-01 EYE DROPS
23
May
2023
Drug Farm Raises $27M USD Financing for Advancement of First-In-Class Hepatitis B and Cardiovascular-Renal Drugs into Clinical Trials
6
Mar
2023
Oculis Announces US Public Listing on NASDAQ